Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biofile Acquires Biofons' ELISA Products

By Labmedica staff writers
Posted on 29 Dec 2004
All rights to the enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody (IFA) products of Biofons (Turku, Finland) have been acquired by Biofile Ltd. More...
(also in Turku). No financial details were disclosed.

All key Biofons personnel from manufacturing and customer service related to the ELISA business have also been transferred from Biofons to Biofile. Biofile now owns all rights to the Biofons brand. Biofile develops, manufactures, and markets innovative diagnostic tests for autoimmune and infectious diseases for private and public clinical laboratories worldwide.

According to Biofile, the new product line will strengthen the company's existing product line. It includes the Biofons celiac disease panel and inflammatory bowel disease panel. The celiac disease panel includes five different tests: anti-gliadin IgA and IgG, anti-transglutaminase IgA and IgG, and endomysium IgA (hUC) IFA test.





Related Links:
Biofile
Biofons

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Urine Analyzer
respons® UDS100
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.